Retina Today’s choice takeaways from this issue.
1. “We believe that [highly concentrated triamcinolone] can be a low-cost and relatively simple treatment for CME. However, considering the incidence of complications experienced in our series, we do not believe it should be used as a first line of treatment.”
—Sjakon G. Tahija, MD; Rini Hersetyati, MD; Ari Djatikusumo, MD; and Valda Garcia, MD, on the use of highly concentrated triamcinolone for treatment of CME
2. “[O]bservation of small uveal melanomas and atypical nevi may be associated with some risk of metastasis.”
—Victor M. Villegas, MD; Aaron S. Gold, OD; and Timothy G. Murray, MD, MBA, on advanced management strategies for malignant melanoma
3. “Surgery for choroidal hemorrhages or choroidal detachments with retinal adhesion (aka, kissing choroidals) or retinal detachment should be expedited.”
—David R.P. Almeida, MD, MBA, PhD, on draining choroidal hemorrhages
4. “VKH disease is an uncommon autoimmune disease with a relatively well-defined clinical course. Clinical symptoms are currently the only way to diagnose VKH.”
—Michael Weaver, MS; and Heeral R. Shah, MD, on making the rare diagnosis of Vogt-Koyanagi-Harada disease
As we ready for takeoff and leave the last major conference of the year behind, we thought we’d take some time to reflect on changes and developments during the previous 11 months and seven issues.
We started 2018 off by welcoming new members to our Editorial Advisory Board (Allen Chiang, MD; S.K. Steven Houston III, MD; Kazuaki Kadonosono, MD; Theodore Leng, MD, MS; Anton Orlin, MD; Aleksandra Rachitskaya, MD; Ehsan Rahimy, MD; and Nadia Waheed, MD, MPH) and officially adding a Medical Retina column, complete with section editors (Jordana G. Fein, MD, MS, and Heeral R. Shah, MD).
This year, we debuted a photo essay column, Visually Speaking, overseen by Manish Nagpal, MS, DO, FRCS (Edin), and we started a new special section of the publication, Business Matters, which piggybacks with four of Retina Today’s eight annual issues, including this one. Be sure to check it out for interesting and informative articles on finance, practice management, coding, and much more.
We also saw many colleagues continuing to share surgical and clinical videos to Eyetube’s retina channel, adding to this already robust online resource. In these pages, Eyetube’s Retina Chief, Michael A. Klufas, MD, and his fellow David Xu, MD, share their 10 favorite surgical videos from 2018.
Throughout the year, many drugs, clinical trials, products, and devices made headlines. If you’re looking for a quick roundup of these milestones, RT’s Assistant Editor, Michele Corry, put together a nice recap. It’s a good reminder of the many areas in which our amazing field of medicine continues to grow and improve.
It’s been another good year for health care in general and for retina specifically. We close our tray tables and return our seats to their upright positions knowing that, as retina specialists, we are part of a unique and impressive breed—one that makes a difference in the lives of patients and regularly contributes to the greater good. We can all take pride in this fact.
Until the next issue, be well, and safe travels.
Allen C. Ho, MD
Chief Medical Editor
Robert L. Avery, MD
Associate Medical Editor